Stefano Ferrari
Gründer bei Chestnut Hill Sciences LLC
Profil
Stefano Ferrari is the founder of Chestnut Hill Sciences LLC, founded in 2004, where he holds the title of Member.
He was also the founder of Murami Pharma, Inc., founded in 2011, where he held the title of Chief Executive Officer.
Mr. Ferrari's current job(s) include being the Chief Executive Officer & Director at Prime Acquisition, Inc. since 2013, a Director at Matinas BioPharma, Inc. since 2012, and the President of Carigent Therapeutics, Inc.Mr. Ferrari's former job(s) include being the Chief Executive Officer at Bioseutica B.V., an Independent Director at Matinas BioPharma Holdings, Inc. from 2013 to 2018, and a Director at Ikonisys, Inc. He also served as a Director at the Richard B.
Fisher Center for the Performing Arts.
Mr. Ferrari's education history includes completing his undergraduate degree at the University of San Francisco.
Aktive Positionen von Stefano Ferrari
| Unternehmen | Position | Beginn |
|---|---|---|
Chestnut Hill Sciences LLC
 Chestnut Hill Sciences LLC Miscellaneous Commercial ServicesCommercial Services Chestnut Hill Sciences LLC provides business services. The private company is based in Rhinebeck, NY. The company was founded by Stefano Ferrari. | Gründer | 01.01.2004 |
| Matinas BioPharma, Inc. | Direktor/Vorstandsmitglied | 01.10.2012 |
Prime Acquisition, Inc.
 Prime Acquisition, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NeuBase Therapeutics, Inc., Prime Acquisition, Inc. is an acquisition vehicle. The company is based in Rhinebeck, NY. Stefano Ferrari has been the CEO of the company since 2013. | Vorstandsvorsitzender | 01.10.2013 |
Carigent Therapeutics, Inc.
 Carigent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carigent Therapeutics, Inc. develops pharmaceutical products. The firm delivers drugs and provides development and commercialization of innovative medical treatments. The company was founded by W. Mark Saltzman in January 26, 2007 and is headquartered in New Haven, CT. | Präsident | - |
Ehemalige bekannte Positionen von Stefano Ferrari
| Unternehmen | Position | Ende |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Direktor/Vorstandsmitglied | 01.01.2018 |
Bioseutica B.V.
 Bioseutica B.V. Chemicals: Major DiversifiedProcess Industries Bioseutica B.V. manufactures proteins for the food, feed, and pharmaceutical sectors. The private company is based in Lugano, Switzerland, and has subsidiaries in Belgium. | Vorstandsvorsitzender | - |
| Richard B. Fisher Center for the Performing Arts | Direktor/Vorstandsmitglied | - |
| Murami Pharma, Inc. | Vorstandsvorsitzender | - |
Ikonisys, Inc.
 Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | - |
Ausbildung von Stefano Ferrari
| University of San Francisco | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Carigent Therapeutics, Inc.
Carigent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carigent Therapeutics, Inc. develops pharmaceutical products. The firm delivers drugs and provides development and commercialization of innovative medical treatments. The company was founded by W. Mark Saltzman in January 26, 2007 and is headquartered in New Haven, CT. | Health Technology |
| Matinas BioPharma, Inc. | |
Ikonisys, Inc.
Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Health Technology |
Prime Acquisition, Inc.
Prime Acquisition, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NeuBase Therapeutics, Inc., Prime Acquisition, Inc. is an acquisition vehicle. The company is based in Rhinebeck, NY. Stefano Ferrari has been the CEO of the company since 2013. | Commercial Services |
Bioseutica B.V.
Bioseutica B.V. Chemicals: Major DiversifiedProcess Industries Bioseutica B.V. manufactures proteins for the food, feed, and pharmaceutical sectors. The private company is based in Lugano, Switzerland, and has subsidiaries in Belgium. | Process Industries |
| Richard B. Fisher Center for the Performing Arts | |
Chestnut Hill Sciences LLC
Chestnut Hill Sciences LLC Miscellaneous Commercial ServicesCommercial Services Chestnut Hill Sciences LLC provides business services. The private company is based in Rhinebeck, NY. The company was founded by Stefano Ferrari. | Commercial Services |
| Murami Pharma, Inc. |
